ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166237; 2) Community: the network communities that were significantly associated with the response to NSC 166237; 3) Molecule: the relationships between components within communities and NSC 166237; 4) MDR: the compounds that were significantly associated with the NSC 166237.

NSC Compound Enrichment Correlation
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.0100995289754787 0.55140069
NSC 374028 Camptothecin Derivative 0.0100995289754787 0.58610123
NSC 610458 Camptothecin Derivative 0.0100995289754787 0.62836581
NSC 639186 Raltitrexed 0.0100995289754787 0.27224789
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.0100995289754787 0.25841714
NSC 659162 1H-Benzimidazole, 5,5'-dithiobis[2-(trifluoromethyl)- (9CI) 0.0100995289754787 0.18634733
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0100995289754787 0.53149216
NSC 668523 N,N-bis(2-chloropropyl)-N-methylammonium chloride 0.0100995289754787 0.56981278
NSC 681635 Camptothecin Derivative 0.0100995289754787 0.51652034
NSC 681639 Camptothecin Derivative 0.0100995289754787 0.52233046
Total:64  Current:20    [First] [Prev] [Next] [Last]